Foster Dykema Cabot & Partners, LLC Abbott Laboratories Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.28 Trillion
- Q4 2024
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 6,049 shares of ABT stock, worth $829,559. This represents 0.05% of its overall portfolio holdings.
Number of Shares
6,049
Previous 7,494
19.28%
Holding current value
$829,559
Previous $854 Million
19.92%
% of portfolio
0.05%
Previous 0.07%
Shares
5 transactions
Others Institutions Holding ABT
# of Institutions
3,372Shares Held
1.36BCall Options Held
10.6MPut Options Held
8.73M-
Vanguard Group Inc Valley Forge, PA169MShares$23.1 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$18 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.6 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$9.32 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.42 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $240B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...